Butterfly Network to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024
07 Novembre 2024 - 2:05PM
Business Wire
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital
health company transforming care with handheld, whole-body
ultrasound and intuitive software, today announced its
participation at the Canaccord Genuity (CG) MedTech, Diagnostics
and Digital Health & Services Forum in New York City on
November 21, 2024.
Joseph DeVivo, President, Chief Executive Officer &
Chairman, and Heather Getz, Executive Vice President & Chief
Financial and Operations Officer will host one-on-one meetings
throughout the day, and Mr. DeVivo will deliver a business overview
presentation at 11:00 am ET.
A webcast of the presentation will be posted to the Events &
Presentations section of the Butterfly investor website, and
available for replay until February 19, 2025.
To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz,
please reach out to your CG representative.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a
digital health company with a mission to democratize medical
imaging by making high-quality ultrasound affordable, easy-to-use,
globally accessible, and intelligently connected, including for the
4.7 billion people around the world lacking access to ultrasound.
Butterfly created the world's first handheld single-probe,
whole-body ultrasound system using semiconductor technology,
Butterfly iQ. The company has continued to innovate, leveraging the
benefits of Moore’s Law, to launch its second generation Butterfly
iQ+ in 2020, and third generation iQ3 in 2024 – each with increased
processing power and performance enhancements. The disruptive
technology has been recognized by TIME’s Best Inventions, Fast
Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech
Breakthrough Awards, among other accolades. With its proprietary
Ultrasound-on-Chip™ technology, intelligent software, and
educational offerings, Butterfly is paving the way to mass adoption
of ultrasound for earlier detection and remote management of health
conditions around the world. Butterfly devices are commercially
available to trained healthcare practitioners in areas including,
but not limited to, parts of Africa, Asia, Australia, Europe, the
Middle East, North America and South America; to learn more about
available countries, visit:
butterflynetwork.com/choose-your-country.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241107932509/en/
Butterfly Investors: Heather Getz Chief Financial and
Operations Officer, Butterfly investors@butterflynetwork.com
Grafico Azioni Butterfly Network (NYSE:BFLY)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Butterfly Network (NYSE:BFLY)
Storico
Da Dic 2023 a Dic 2024